Link Silicon Valley
The fastest way to connect to the people, companies and capital of Silicon Valley
Free 30 Day Trial Account
Sign Up | Log In
My Lists

VIVUS  (Stock symbol: VVUS )

900 E. Hamilton Ave. #500
Campbell, CA 95008
Website Company Summary Management Team

CEO: Seth H Z Fischer (9/3/2013)
President/COO/Operations: Guy P Marsh (5/98)
General Management: Barbara Troupin (3/27/2012) ; Malcolm McKay (6/30/2010) ; Santosh T Varghese (3/27/2012) ; Ted Broman (1/06) ; Wesley W Day (11/17/2005)
Finance: Lee B Perry (02/27/2007) ; Mark K Oki (10/31/2015)
Technology: John Dietrich (10/00); Virgil A Place
Sales/Marketing: Alfred Tenuto ; Chris Thompson
Business Development: Changjin Wang; Michael P Miller
General Counsel/Legal: Sandra Wells ; John Slebir

Outside board: (May no longer be on the board) Charles J Casamento (Osteologix Former CEO) Ernest Mario (Soleno Therapeutics) Linda M Shortliffe (Stanford University Professor) Michael Astrue (Transkaryotic Therapies Former CEO);  Mark B Logan (VISX Former President/CEO)

Business description: VIVUS, Inc. (NASDAQ: VVUS) is a pharmaceutical company engaged in developing, acquiring and marketing innovative products to improve quality of life disorders in men and women, with a focus on sexual dysfunction.  VIVUS’ goal is to establish a robust pipeline consisting of drug candidates at various stages of development, with a focus on innovative therapies intended to serve large and unsatisfied markets. In addition to the Company’s currently marketed products, MUSE® and ACTIS®, VIVUS is developing products for male erectile dysfunction, female sexual dysfunction, and premature ejaculation. The Company believes that patients with these conditions are not being adequately treated, and VIVUS has the expertise and intellectual property necessary to make meaningful contributions in these areas.
Partners include: Astra AB;  Bio-Medic Institute;  Deerfield Management ;  MEDA;  Paladin;  Tanabe

Capital raised: 35.0M
Ownership: Public  
Stock Symbol: VVUS
Corporate investors: Shooter FinancialGE Capital

Last Tweets


Last Mentions

Record updated: Nov 2013
Sector: Biotech
Year Founded: 1991
Headcount: 51-75 as of Jun 2020
Capital Raised: 35.0M
Ownership: Public  
Stock Symbol: VVUS